InnoCare Pharma Ltd
HKEX:9969

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
HKEX:9969
Watchlist
Price: 11.81 HKD 0.17% Market Closed
Market Cap: HK$20.8B

Profitability Summary

InnoCare Pharma Ltd's profitability score is 30/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

30/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

30/100
Profitability
Score
30/100
Profitability
Score

Margins

Earnings Waterfall
InnoCare Pharma Ltd

Margins Comparison
InnoCare Pharma Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
InnoCare Pharma Ltd
SSE:688428
17.1B CNY
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.1B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
167.9B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.8B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
InnoCare Pharma Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
InnoCare Pharma Ltd
SSE:688428
17.1B CNY
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
167.9B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.8B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
InnoCare Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate